NRC expected to issue Mo-99 facility license for Shine in 2021

May 13, 2020, 9:10PMNuclear News

Shine Medical Technologies, which is building a medical isotope production facility in Janesville, Wis., said on May 11 that it expects to have an operating license issued by the Nuclear Regulatory Commission by October 2021. Shine’s application seeking approval to operate the facility, which will produce isotopes including molybdenum-99, was accepted and docketed by the NRC last October. Mo-99, the precursor to technetium-99m, is used in more than 40 million medical patient procedures every year.

To continue reading, log in or create a free account!

Related Articles

Ian Wall—ANS member since 1964

September 10, 2024, 3:01PMNuclear News

I graduated with a degree in mechanical engineering from Imperial College, London, in 1958. Nuclear power was viewed favorably at the time, so I took a 1-year course on the subject. I was then...

Finding the courage to dance

September 9, 2024, 7:00AMNuclear News

I recently attended the 2024 Utility Working Conference where, despite the widespread travel disruptions created by Tropical Storm Debby, nearly 600 folks from the U.S. nuclear utility and...